Evidence map›Paper›PMID 39488792›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2024

Endosomal Trafficking Bypassed by the RAB5B-CD109 Interplay Promotes Axonogenesis in KRAS-Mutant Pancreatic Cancer.

Dingwen Zhang, Yuming Luo, Yan Lin, Zhou Fang, Hanhao Zheng, Mingjie An, Qingyu Xie, Zhuo Wu, Chao Yu, Jiabin Yang and 3 more

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Dingwen ZhangSchool of Medicine, South China University of Technology, Guangzhou, Guangdong, 510006, P. R. China.
Yuming LuoDepartment of Pancreatic Surgery, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, 510080, P. R. China.
Yan LinDepartment of Urology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, 510120, P. R. China.
Zhou FangDepartment of Pancreatic Surgery, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, 510080, P. R. China.
Hanhao ZhengDepartment of Urology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, 510120, P. R. China.
Mingjie AnDepartment of Urology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, 510120, P. R. China.
Qingyu XieDepartment of Pancreatic Surgery, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, 510080, P. R. China.
Zhuo WuSchool of Medicine, South China University of Technology, Guangzhou, Guangdong, 510006, P. R. China.
Chao YuDepartment of Pancreatic Surgery, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, 510080, P. R. China.
Jiabin YangDepartment of Pancreatic Surgery, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, 510080, P. R. China.
Min YuDepartment of Pancreatic Surgery, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, 510080, P. R. China.
Changhao ChenDepartment of Urology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, 510120, P. R. China.
Rufu ChenDepartment of Pancreatic Surgery, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, 510080, P. R. China.ORCID 0000-0002-1883-1780

Funding

Guangdong Basic and Applied Basic Research Foundation 2021A1515010355Guangdong Basic and Applied Basic Research Foundation 2021B1515020091Guangdong Basic and Applied Basic Research Foundation 2022A1515012288Guangdong Basic and Applied Basic Research Foundation 2023A1515011648Key Technologies Research and Development Program 2018YFA0902803Key Technologies Research and Development Program 2022YFA1305500National Science Foundation 82072639National Science Foundation 82103416National Science Foundation 82103536National Science Foundation 82173272National Science Foundation 82202276National Science Foundation 82203691
6 · The paper itself

Abstract

Perineural invasion (PNI) represents a unique biological feature associated with poor prognosis in pancreatic ductal adenocarcinoma (PDAC), especially in the presence of KRAS mutations. Extracellular vesicle (EV)-packaged circular RNAs (circRNAs) function as essential mediators of tumor microenvironment communication, triggering PDAC cell invasion and distant metastasis. However, the regulatory mechanisms of EV-packaged circRNAs in the PNI of KRAS-mutant PDAC have not yet been elucidated. Herein, a KRAS

Indexed as

Carcinoma, Pancreatic DuctalPancreatic NeoplasmsProto-Oncogene Proteins p21(ras)rab5 GTP-Binding ProteinsRNA, CircularAnimalsCell Line, TumorDisease Models, AnimalEndosomesHumansMiceMutationKRAS protein, humanProto-Oncogene Proteins p21(ras)rab5 GTP-Binding ProteinsRNA, Circularcircular RNAengineered extracellular vesicleKRAS mutationpancreatic cancerperineural invasion

Identifiers

PMID39488792
PMCPMC11653710

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.